Is Eli Lilly stock a good investment?

Eli Lilly stock has been a very good investment over the years. The company has delivered a total annual return of over 28% over the last decade, more than double the average S&P 500 return (over 11%). A big driver has been its success in developing blockbuster drugs. The company's portfolio features several growth products and new drugs that should continue driving its revenue and profitability higher. Its profit growth should enable Eli Lilly to grow its dividend while potentially helping it to continue producing strong stock price appreciation. However, the company does trade at a high valuation (more than 30 times forward earnings in early 2025). It can grow into that valuation as long as its new and growth products continue increasing sales and earnings at brisk rates.

How do I buy shares of Eli Lilly?

It's easy to buy shares of Eli Lilly. You need to open a brokerage account (if you don't have one already), figure out your budget, thoroughly research the company, and place an order when you're ready to buy shares. To place an order, you'd fill out the order page in your brokerage account, including:The number of shares you want to buyThe correct stock ticker (LLY for Eli Lilly)The order type (limit order or market order)Once you fill out the order page, click to submit your trade to buy shares of Eli Lilly.

Is Eli Lilly a good long-term stock?

Eli Lilly has historically been a good long-term stock investment. Over the last decade, the pharmaceutical stock has delivered an average annual return of 28%, more than double the return of the S&P 500 (around 11% annually). While past performance is no guarantee that the company will deliver strong returns in the future, it has a lot going for it these days. Growth products like Jardiance, Taltz, and Trulicity are increasing sales rapidly. Meanwhile, new product launches like Mounjaro and Zepbound are off to a strong start and have become notable growth products. Rising sales from these and other drugs should drive the company's profits higher, giving it more money to invest in R&D and return to shareholders through a growing dividend and share repurchases. Those factors have historically been key hallmarks of good long-term investments.

Who owns the most Eli Lilly stock?

The Lilly Endowment owned the most Eli Lilly stock in early 2025. It held more than 96 million shares (about 10.2% of its outstanding shares) worth roughly $87.1 billion. The Lilly Endowment is a private philanthropic foundation formed by J. K. Lilly, Sr., and his sons Eli and J. K., Jr., through gifts of stock in their pharmaceutical company, Eli Lilly.

How to Buy Eli Lilly Stock (LLY)

By Matthew DiLallo – Updated Jan 9, 2026 at 4:59 PM EST | Fact-checked by Frank Bass

Key Points

Eli Lilly launched a couple of new successful drugs, Mounjaro and Zepbound, that have boosted its market value.
The company's revenue and profits are expected to double in 2025 due to strong sales from those new blockbuster drugs.
Investors can purchase Eli Lilly stock through their brokerage account.

Eli Lilly (LLY +0.67%) is a leading pharmaceutical company. It has developed several blockbuster products, including Trulicity (type 2 diabetes), Taltz (plaque psoriasis), and Jardiance (blood sugar). These and other drugs generate billions in sales and profits for the company each year.

The drug company recently added a couple more blockbuster drugs to its portfolio by launching Mounjaro (diabetes) and Zepbound (obesity). They're already generating billions of dollars in revenue for the company.

Loading paragraph...

The sales potential of these new drugs and the company's other therapies has many investors interested in the stock. Here's everything you need to know about how to invest in Eli Lilly.

How to buy Eli Lilly stock

This step-by-step guide will show you how to invest in Eli Lilly.

Open your brokerage app: Log in to your brokerage account where you handle your investments. If you don't have one yet, take a look at our favorite brokers and trading platforms to find the right one for you.
Search for Eli Lilly: Enter the ticker "LLY" into the search bar to bring up the stock's trading page.
Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
Submit your order: Confirm the details and submit your buy order.
Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.

Loading paragraph...

Should you invest in Eli Lilly?

You need to decide whether investing in Eli Lilly is right for you. Here are some factors that could lead you to buy the pharmaceutical stock:

You believe Zepbound has better sales potential than rival Novo Nordisk's (NVO -1.85%) Wegovy.
You take one or more medications made by Eli Lilly.
Adding Eli Lilly to your portfolio would help make it more diversified.
You understand the risks of investing in pharmaceutical stocks, including the fact that they can lose money.
You want to invest in a company that pays a growing dividend.
You believe Eli Lilly can grow into its high valuation.

Loading paragraph...

On the other hand, here are some reasons you might decide Eli Lilly isn't the right stock for you to buy:

You're wary of pharmaceutical companies and prefer a more natural approach to health and wellness.
You're unsure whether weight-loss drugs like Zepbound will live up to the hype.
You're in or nearing retirement and need more dividend income than Eli Lilly can supply.
You're concerned about Eli Lilly's high valuation (it had a forward price-to-earnings (P/E) ratio of more than 30 times in early 2025).
You already own several pharmaceutical stocks.
You're concerned about how U.S. Health and Human Services Secretary Robert F. Kennedy Jr. might affect the pharmaceutical industry.

Loading paragraph...

NYSE: LLY

Eli Lilly

Today's Change

(0.67%) $7.50

Current Price

$1132.77

Key Data Points

Market Cap

$1.1T

Day's Range

$1131.03 - $1166.19

52wk Range

$623.78 - $1166.29

Volume

217.4K

Avg Vol

3.1M

Gross Margin

82.83%

Dividend Yield

0.57%

Loading company_card...

Is Eli Lilly profitable?

Digging into a company's profitability is essential because earnings tend to drive a stock's price over the long term. Given this dynamic, you'll want to see that the company is increasing its earnings or at least on the path toward profitability.

Eli Lilly is very profitable. The company reported $10.6 billion, or $11.71 per share, of net income in 2024 on $45 billion of revenue. Revenue was up 32% while earnings soared 102%.

The company expects to deliver another year of significant earnings growth in 2025. Its initial guidance has revenue growing to a range of $58 billion to $61 billion (32% growth at the midpoint), with earnings per share roughly doubling to between $22.05 and $23.55. New product sales are a big factor driving this view, including the continued growth of weight loss drug Zepbound and additional launches of Mounjaro outside of the U.S.

Loading paragraph...

Does Eli Lilly pay a dividend?

Eli Lilly has a long history of paying dividends. It has increased its payout annually for over a decade. It has been growing its payout at an accelerated pace in recent years, delivering its seventh straight year of hiking its dividend by 15% in late 2024:

Loading paragraph...

Loading image...

While the company pays a growing dividend, it offered a below-average dividend yield (0.8% in early 2025 compared to around 1.5% for the S&P 500).

How to invest in Eli Lilly through ETFs

Many investors prefer a passive approach to actively managing a portfolio of stocks. Exchange-traded funds (ETFs) make this easy. They allow you to passively invest in similar companies, market indexes, or other themes.

Loading paragraph...

Exchange-Traded Fund (ETF)

An exchange-traded fund, or ETF, allows investors to buy many stocks or bonds at once.

Loading definition...

Loading paragraph...

Data source: Eli Lilly.
Split Year	Split Ratio
1997	2-for-1
1995	2-for-1
1989	2-for-1
1986	2-for-1
1971	2-for-1

Loading table...

The company's last split came in 1997. Shares have gained significant value since then, trading at more than $700 in early 2025. Its high share price makes the stock less accessible to many investors, so Eli Lilly is an excellent candidate to complete a stock split in the future.

The bottom line

Eli Lilly has grown into one of the world's largest pharmaceutical companies thanks to the blockbuster success of its drug development efforts. The company expects its revenue and profitability to continue rising, driven by new products like Zepbound and Mounjaro. That profit growth could send its stock even higher in the future, potentially making it a very rewarding long-term investment.

Loading paragraph...

FAQ

Investing in Eli Lilly FAQ

Loading faq...

About the Author

Matt DiLallo has been a contributing Motley Fool stock analyst specializing in the energy, industrials, and real estate sectors since 2012. He also covers dividend-paying stocks, pre-IPO companies, ETFs, and other investing topics. He holds an MBA from Liberty University.

TMFmd19

@MatthewDiLallo

Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vanguard Total Stock Market ETF. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy.

How to Buy Eli Lilly Stock (LLY)

Key Points

How to buy Eli Lilly stock

Should you invest in Eli Lilly?

NYSE: LLY

Key Data Points

Is Eli Lilly profitable?

Does Eli Lilly pay a dividend?

How to invest in Eli Lilly through ETFs

Exchange-Traded Fund (ETF)

The bottom line

Related investing topics

How to Buy Pfizer Stock (PFE)

How to Buy CRISPR Therapeutics Stock (CRSP)

How to Buy Intuitive Surgical Stock (ISRG)

How to Buy Johnson & Johnson Stock (JNJ)

FAQ

Investing in Eli Lilly FAQ

Is Eli Lilly stock a good investment?

Is Eli Lilly stock a good investment?

How do I buy shares of Eli Lilly?

How do I buy shares of Eli Lilly?

Is Eli Lilly a good long-term stock?

Is Eli Lilly a good long-term stock?

Who owns the most Eli Lilly stock?

Who owns the most Eli Lilly stock?

About the Author

Read Next

Stocks Mentioned

Motley Fool Stock Advisor’s Latest Pick

Premium Investing Services

How to buy Eli Lilly stock

Should you invest in Eli Lilly?

NYSE: LLY

Key Data Points

Is Eli Lilly profitable?

Does Eli Lilly pay a dividend?

How to invest in Eli Lilly through ETFs

Exchange-Traded Fund (ETF)

The bottom line

How to Buy Pfizer Stock (PFE)

How to Buy CRISPR Therapeutics Stock (CRSP)

How to Buy Intuitive Surgical Stock (ISRG)

How to Buy Johnson & Johnson Stock (JNJ)

Investing in Eli Lilly FAQ

Is Eli Lilly stock a good investment?

Is Eli Lilly stock a good investment?

How do I buy shares of Eli Lilly?

How do I buy shares of Eli Lilly?

Is Eli Lilly a good long-term stock?

Is Eli Lilly a good long-term stock?

Who owns the most Eli Lilly stock?

Who owns the most Eli Lilly stock?

Will Eli Lilly stock split?